SOPHIE Commercialization Projects OVERVIEW
In partnership with Innovation Factory, leverage up to $100,000 in funding to work directly with an academic or hospital partner in the Hamilton ecosystem. This funding will support collaborative projects for Ontario-based life science firms requiring clinical/research expertise, evidence, or data to commercialize their innovation, increase their sales or secure a “first buyer”. This funding will bridge access to Hamilton’s unique life sciences capabilities and research expertise with the needs of life sciences companies that are in late stages of commercialization and in need of financing to get to technology validation and first sale.
SOPHIE Commercialization Project BENEFITS
Who Should Apply
- Private life science companies based in Ontario
- Working on commercializing an innovative technology at TRL-6 (or above)
- Demonstrated commitment to commercializing innovation with a clear clinical application
SOPHIE Commercialization Projects operates under a rolling admission, and will be accepting applications through 2023.
SOPHIE Program Guide
Please review the SOPHIE Program Guide link below prior to starting your application.
SOPHIE Program Guide – October 2022
SOPHIE Presentation –
Hamilton Health Check-Up
SOPHIE Presentation July 2021 (PDF)List of Approved SOPHIE Companies
Hear directly from innovators who have leveraged the SOPHIE program to accelerate their startup’s commercialization success:TAMVOES – Innovator Testimonial Allarta Life Science – Innovator Testimonial
Have a question? Contact us:
Alex Muggah | Director | 905.667.2606 | [email protected]
Start your SOPHIE Application Here
Synapse Life Science Consortium is a partnership of the major life science organizations in Hamilton, including the hospitals, University, College, private companies, representing 25,000 employees. Synapse is meant to be a concierge and advocate for the community – with a focus on supporting efforts to commercialize health innovation.